I now have all the material needed for a comprehensive 5-mark answer. Let me compile this into a well-structured answer for an anesthesia residency exam.
Sedation in the ICU
(5 marks - Anesthesia Residency)
1. Goals of ICU Sedation
The primary goal is to provide patient comfort and safety while minimizing adverse effects. An ideally sedated patient:
- Tolerates endotracheal tube and mechanical ventilation (improves oxygenation, reduces ventilator-induced lung injury)
- Does not dislodge catheters, monitoring lines, or self-extubate
- Can participate in early mobilization and physiotherapy
- Is protected from the sympathoadrenal stress response to injury
The key principle is "analgesia-first" - pain should be treated before sedation is added, as many ICU patients are agitated primarily due to inadequately treated pain.
- Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, p. 4857
- Fischer's Mastery of Surgery, 8th e, p. 457
2. Assessment of Sedation - Scoring Scales
Validated scales must be used before and after every intervention.
Richmond Agitation-Sedation Scale (RASS) - Most Widely Used
| Score | Label | Description |
|---|
| +4 | Combative | Overtly combative, violent, immediate danger to staff |
| +3 | Very agitated | Pulls/removes tubes or catheters, aggressive |
| +2 | Agitated | Frequent non-purposeful movement, fights ventilator |
| +1 | Restless | Anxious but movements not aggressive |
| 0 | Alert and calm | Spontaneously attentive |
| -1 | Drowsy | Not fully alert, sustained eye opening >10 sec |
| -2 | Light sedation | Briefly awakens, eye opening <10 sec |
| -3 | Moderate sedation | Movement or eye opening to voice, no eye contact |
| -4 | Deep sedation | No response to voice, movement to physical stimulation |
| -5 | Unarousable | No response to voice or physical stimulation |
Target RASS: -2 to +1 for most ICU patients. Scores below -2 are associated with longer ICU stay and prolonged time to extubation; scores above +1 are associated with self-harm and self-extubation.
Other scales: Ramsay Sedation Scale (RSS), Sedation-Agitation Scale (SAS).
- Fischer's Mastery of Surgery, 8th e, p. 458-459
3. Sedative Agents in the ICU
| Drug | Mechanism | Typical Dose | Half-life | Key Features / Adverse Effects |
|---|
| Propofol | GABA-A agonist | 5-50 mcg/kg/min infusion | Short | Drug of choice for short-term sedation; shorter MV duration vs. BZDs; can cause hypotension, hypertriglyceridemia, propofol infusion syndrome (PRIS) at high doses |
| Midazolam | GABA-A agonist (BZD) | Bolus 1-5 mg; infusion | 3-11 hr | Deep sedation + amnesia; hemodynamically stable; associated with more delirium and prolonged MV; drug of choice for alcohol withdrawal; active metabolites accumulate in renal failure |
| Dexmedetomidine | Alpha-2 agonist (central) | 0.2-0.7 mcg/kg/hr | Short | Sedation without respiratory depression; analgesic-sparing; preserves arousability ("cooperative sedation"); cannot reliably produce deep sedation; bradycardia and hypotension are limiting adverse effects; not appropriate as sole agent in paralyzed patients |
| Ketamine | NMDA antagonist | 1-2 mcg/kg/hr (adjunct) | Moderate | Opioid-sparing analgesic adjunct; preserves airway reflexes; may increase ICP (caution) |
Key comparison - Propofol vs. Dexmedetomidine vs. Benzodiazepines:
-
Propofol and dexmedetomidine are associated with shorter duration of mechanical ventilation and less delirium than benzodiazepines
-
Benzodiazepine infusions should be reserved for specific indications requiring deep sedation (RASS -4 to -5): status epilepticus, severe ARDS, refractory intracranial hypertension, alcohol withdrawal
-
Propofol is most commonly used, equally efficacious but less expensive than dexmedetomidine, and more reliably produces deep sedation
-
Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, p. 4858
-
Fischer's Mastery of Surgery, 8th e, p. 459-462
4. Analgesic Agents
Analgesia-first (analgo-sedation) strategy is preferred. Common opioids:
- Fentanyl - preferred in hemodynamic instability; short-acting
- Morphine - avoid in renal failure (active metabolite morphine-6-glucuronide accumulates)
- Hydromorphone - alternative in renal impairment
Non-opioid adjuncts (opioid-sparing strategy):
- Acetaminophen (IV/enteral)
- Low-dose ketamine infusion
- NSAIDs (use cautiously - renal and GI effects)
- Gabapentin / Pregabalin (neuropathic pain)
- Regional anesthesia (especially for extremity trauma/surgery)
5. Daily Sedation Interruption (DSI) / Spontaneous Awakening Trial (SAT)
Protocolized daily sedation holds are standard of care:
- Reduces total drug exposure
- Shortens duration of mechanical ventilation
- Decreases ICU length of stay
- Reduces mortality
The "ABCDEF Bundle" (also called the "Liberation Bundle") integrates:
- A - Assess, Prevent, and Manage Pain
- B - Both SAT (Spontaneous Awakening Trial) and SBT (Spontaneous Breathing Trial)
- C - Choice of analgesia and sedation (lightest effective)
- D - Delirium: Assess, Prevent, and Manage
- E - Early Mobility and Exercise
- F - Family Engagement and Empowerment
Exceptions to DSI (where deep sedation is maintained continuously): severe ARDS, refractory ICP, status epilepticus, therapeutic hypothermia after cardiac arrest.
- Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, p. 4859
- Fischer's Mastery of Surgery, 8th e, p. 465
6. ICU Delirium - A Major Complication of Over-Sedation
Definition: Acute brain dysfunction characterized by:
- Acute onset and fluctuating course
- Inattention
- Altered level of consciousness
- Disorganized thinking
Epidemiology: Present in up to 66% of ICU patients. Each day of delirium increases mortality by 10%; 60-day mortality triples and hospital stay doubles with delirium.
Diagnosis: CAM-ICU (Confusion Assessment Method for the ICU) - validated tool with high sensitivity and specificity. Positive CAM-ICU = delirium. Cannot be assessed in comatose patients (RASS -4 to -5).
Risk factors:
- Premorbid: age, prior dementia, alcohol use, frailty
- On admission: sepsis, AKI, liver dysfunction, surgery
- Intra-ICU: deep sedation, immobility, sleep deprivation, polypharmacy, restraints
Management of delirium:
- Non-pharmacologic (first-line): sleep-wake cycle normalization, early mobilization, minimizing disruptions, family involvement, sensory aids (glasses, hearing aids)
- Pharmacologic: Antipsychotics (haloperidol, quetiapine) for agitation - no proven mortality benefit but reduce agitation safely; avoid benzodiazepines (worsen delirium) except in alcohol withdrawal
Post-Intensive Care Syndrome (PICS): Over half of ICU survivors suffer long-term cognitive impairment; PICS-F affects families of ICU patients.
- Fischer's Mastery of Surgery, 8th e, p. 466-472
- Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, p. 4859
Quick Summary Table for Exam
| Feature | Propofol | Dexmedetomidine | Midazolam |
|---|
| Mechanism | GABA-A | Alpha-2 agonist | GABA-A |
| Deep sedation | Yes | No | Yes |
| Amnesia | Yes | No | Yes |
| Respiratory depression | Yes | Minimal | Yes |
| Hemodynamics | Hypotension | Bradycardia/Hypotension | Stable |
| Delirium risk | Low | Lowest | High |
| Cost | Low | Higher | Low |
| Special concern | PRIS (high dose/long duration) | Cannot use as sole agent with paralysis | Avoid in renal failure; prolongs MV |
Key exam points:
- Prefer propofol or dexmedetomidine over benzodiazepines for most ICU patients
- RASS target -2 to +1 for most mechanically ventilated patients
- Daily sedation interruption is mandatory unless contraindicated
- CAM-ICU is the standard delirium screening tool
- Analgo-sedation (analgesia-first) is the modern approach - treat pain before adding sedatives
- Propofol infusion syndrome (PRIS): metabolic acidosis + rhabdomyolysis + cardiac failure - occurs with >4 mg/kg/hr for >48 hours; monitor triglycerides and CK